Literature DB >> 26841714

Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis.

Britta C Martel1,2,3, Thomas Litman3, Andreas Hald3, Hanne Norsgaard3, Paola Lovato3, Beatrice Dyring-Andersen1, Lone Skov1, Kristian Thestrup-Pedersen1, Søren Skov2, Kresten Skak3, Lars K Poulsen1.   

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disease with underlying defects in epidermal function and immune responses. In this study, we used microarray analysis to investigate differences in gene expression in lesional skin from patients with mild extrinsic or intrinsic AD compared to skin from healthy controls and from lesional psoriasis skin. The primary aim was to identify differentially expressed genes involved in skin barrier formation and inflammation, and to compare our results with those reported for patients with moderate and severe AD. In contrast to severe AD, expression of the majority of genes associated with skin barrier formation was unchanged or upregulated in patients with mild AD compared to normal healthy skin. Among these, no significant differences in the expression of filaggrin (FLG) and loricrin at both mRNA and protein level were found in lesional skin from patients with mild AD, despite the presence of heterozygous FLG mutations in the majority of patients with mild extrinsic AD. Several inflammation-associated genes such as S100A9, MMP12, CXCL10 and CCL18 were highly expressed in lesional skin from patients with mild psoriasis and were also increased in patients with mild extrinsic and intrinsic AD similar to previous reports for severe AD. Interestingly, expression of genes involved in inflammatory responses in intrinsic AD resembled that of psoriasis more than that of extrinsic AD. Overall, differences in expression of inflammation-associated genes found among patients with mild intrinsic and extrinsic AD correlated with previous findings for patients with severe intrinsic and extrinsic AD.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  epidermal differentiation complex; inflammation; microarray; psoriasis; skin barrier

Mesh:

Year:  2016        PMID: 26841714     DOI: 10.1111/exd.12967

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  17 in total

1.  Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease.

Authors:  Garrett J Patrick; Haiyun Liu; Martin P Alphonse; Dustin A Dikeman; Christine Youn; Jack C Otterson; Yu Wang; Advaitaa Ravipati; Momina Mazhar; George Denny; Roger V Ortines; Emily Zhang; Robert J Miller; Carly A Dillen; Qi Liu; Sabrina J Nolan; Kristine Nguyen; LeeAnn Marcello; Danh C Do; Eric M Wier; Yan Zhang; Gary Caviness; Alexander C Klimowicz; Diane V Mierz; Jay S Fine; Guangping Sun; Raphaela Goldbach-Mansky; Alina I Marusina; Alexander A Merleev; Emanual Maverakis; Luis A Garza; Joshua D Milner; Peisong Gao; Meera Ramanujam; Ernest L Raymond; Nathan K Archer; Lloyd S Miller
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 2.  Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials.

Authors:  Gaurav Agnihotri; Peter A Lio
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

3.  Identification of Molecular Signatures in Mild Intrinsic Atopic Dermatitis by Bioinformatics Analysis.

Authors:  Huibin Yin; Shangshang Wang; Chaoying Gu
Journal:  Ann Dermatol       Date:  2020-03-11       Impact factor: 1.444

Review 4.  Atopic dermatitis phenotypes and the need for personalized medicine.

Authors:  Beatriz Cabanillas; Ann-Christin Brehler; Natalija Novak
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-08

5.  TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis.

Authors:  Daniel Sidler; Ping Wu; Rana Herro; Meike Claus; Dennis Wolf; Yuko Kawakami; Toshiaki Kawakami; Linda Burkly; Michael Croft
Journal:  Nat Commun       Date:  2017-05-22       Impact factor: 14.919

Review 6.  S100A8/A9 in Inflammation.

Authors:  Siwen Wang; Rui Song; Ziyi Wang; Zhaocheng Jing; Shaoxiong Wang; Jian Ma
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

Review 7.  Leveraging Multilayered "Omics" Data for Atopic Dermatitis: A Road Map to Precision Medicine.

Authors:  Debajyoti Ghosh; Jonathan A Bernstein; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

Review 8.  Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.

Authors:  Thomas Litman
Journal:  APMIS       Date:  2019-05       Impact factor: 3.205

9.  Atopic Dermatitis and Psoriasis as Overlapping Syndromes.

Authors:  A Bozek; M Zajac; M Krupka
Journal:  Mediators Inflamm       Date:  2020-11-27       Impact factor: 4.711

10.  Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes.

Authors:  Rebecca Riise; Lina Odqvist; Johan Mattsson; Susan Monkley; Suado M Abdillahi; Christian Tyrchan; Daniel Muthas; Linda Fahlén Yrlid
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.